Transforming growth factor beta-1 (TCFP-I), known as an inhibitor of vascular endothelial cell proliferation in vitro, stimulates bovine corneal endothelial cells (BCE) proliferation. It also positively modulates the response of BCE cells to fibroblast growth factor (FGF) and epidermal growth factor
Transforming Growth Factor-β1-Antisense Modulates the Expression of Hepatocyte Growth Factor/Scatter Factor in Keloid Fibroblast Cell Culture
✍ Scribed by R. Naim; A. Naumann; J. Barnes; A. Sauter; K. Hormann; D. Merkel; W. Aust; T. Braun; M. Bloching
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 384 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0364-216X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatocyte growth factor, a potent hepatocyte mitogen in vitro, appears to trigger hepatocyte regeneration after partial hepatectomy and after acute liver cell netcrosis. Transforming growth factor-a and transforming growth factor+, may also be involved in the control of liver regeneration. In this
After a partial hepatectomy, TGF-a mRNA has been shown of chronic liver disease; CH, chronic hepatitis; LC, liver cirrhosis; LI, labeling index; RTto increase in hepatocytes at the time of DNA synthesis con-PCR, reverse-transcriptase polymerase chain reaction; cDNA, complementary DNA.
Basic fibroblast growth factor (bFGF) and transforming growth factor beta 1 (TGFP1) are potential autocrine growth regulators of the prostatic stroma, and therefore may play a role in the development of benign prostatic hyperplasia (BPH). We reported [Story et al.: Prostate 22:183-197, 19931 that TG